These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3041661

  • 21. Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.
    Labar B, Masszi T, Morabito F, Mistrik M, Holowiecki J, Bogdanić V, Nemet D, Mrsić M, Krieger O, Lutz D.
    Bone Marrow Transplant; 1996 Jun; 17(6):1009-12. PubMed ID: 8807107
    [Abstract] [Full Text] [Related]

  • 22. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC.
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [Abstract] [Full Text] [Related]

  • 23. Bone marrow graft in acute leukemia [proceedings].
    Devergie A, Gluckman E, Marty M, Bussel A.
    Pathol Biol (Paris); 1978 Jan; 26(1):45. PubMed ID: 358085
    [No Abstract] [Full Text] [Related]

  • 24. Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.
    Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Fialkow PJ, Funk DD, Neiman PE, Rudolph RH, Slichter SJ, Storb R.
    Trans Assoc Am Physicians; 1971 Jan; 84():248-61. PubMed ID: 4151544
    [No Abstract] [Full Text] [Related]

  • 25. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
    Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, Abhyankar S, Lamb LS.
    Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
    [Abstract] [Full Text] [Related]

  • 26. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.
    Kumar S, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Tefferi A, Litzow MR.
    Bone Marrow Transplant; 2001 Nov; 28(10):951-6. PubMed ID: 11753550
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T, Kurrle E, Arnold R, Heit W, Krieger D, Kubanek B, Heimpel H.
    Prog Clin Biol Res; 1985 Jul; 181():433-5. PubMed ID: 3895247
    [No Abstract] [Full Text] [Related]

  • 30. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 31. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
    Gowing H, Braakman E, Hagenbeek A, Lawler M, McCann SR, Pamphilon DH, Martens AC.
    Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S, Mavroudis D, Jiang YZ, Hensel N, Molldrem J, Barrett AJ.
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [Abstract] [Full Text] [Related]

  • 35. [Bone marrow transplantation in pediatric patients: review of progress].
    Inoue S.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):994-1003. PubMed ID: 3551848
    [No Abstract] [Full Text] [Related]

  • 36. Prevention of graft versus host disease following allogeneic bone marrow transplantation.
    Powles RL, Goss GD, Millar J, Maitland J, Borthwick-Clark C, Al-Jundi A.
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Bone marrow transplantation after intensive chemotherapy].
    Masaoka T.
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
    [Abstract] [Full Text] [Related]

  • 39. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J.
    J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801
    [Abstract] [Full Text] [Related]

  • 40. Autologous bone marrow transplantation in relapsed acute leukemias and chronic myeloid leukemia in blast crisis.
    Izzi T, Moretti L, Polchi P, Galimberti M, Delfini C, Porcellini A, Lucarelli G.
    Haematologica; 1983 Feb 01; 68(3):368-80. PubMed ID: 6411531
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.